The once daily tablet is expected to reach US patients in October 2026.
|Slideshows|August 15, 2019
- Drug Topics August 2019
- Volume 163
- Issue 8
Pharmacy Financial Statements: The Numbers that Count
Author(s)Scotty W. Sykes, CPA, CGMA
Advertisement
Articles in this issue
about 7 years ago
Reaching a New Generation of Consumersabout 7 years ago
New Drug Review: Vraylar for Bipolar I Disorderabout 7 years ago
AI in the Pharmacyabout 7 years ago
Zolgensma: The $2.1 Million Drugabout 7 years ago
Physician Dispensing and the Opioid Crisisabout 7 years ago
Psychotropics for Childrenabout 7 years ago
Improving the Customer Experienceabout 7 years ago
Birth Control Services Help Attract and Keep Patientsabout 7 years ago
Prevalence and Prevention of Sexual Harassment in the Pharmacyabout 7 years ago
Opinion: Clinician Burnout is Everyone's ProblemAdvertisement
Related to this article
The label expansion adds patients 12 years of age and older to the once daily alopecia areata indication.
Pharmacist and public health expert Jennifer Hammons, PharmD, DrPH, discusses pharmacy as essential infrastructure amid rural pharmacies persistently being overlooked.
An American Heart Association scientific statement shows earlier risk factors and social barriers driving cardiovascular disparities in Hispanic adults.
In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
The investigational anti–IL-33 antibody lowered exacerbation rates across all blood eosinophil levels, a benefit current COPD biologics do not offer.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
A study finds children starting continuous glucose monitoring within a month of diagnosis sustained lower hemoglobin A1C than those who started later.
Advertisement
Advertisement